↓ Skip to main content

Isolation and Molecular Characterization of Circulating Tumor Cells

Overview of attention for book
Cover of 'Isolation and Molecular Characterization of Circulating Tumor Cells'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Circulating Tumor Cells as Cancer Biomarkers in the Clinic
  3. Altmetric Badge
    Chapter 2 Strategies for Isolation and Molecular Profiling of Circulating Tumor Cells
  4. Altmetric Badge
    Chapter 3 Aptamer-Based Methods for Detection of Circulating Tumor Cells and Their Potential for Personalized Diagnostics
  5. Altmetric Badge
    Chapter 4 Development of a Protocol for Single-Cell Analysis of Circulating Tumor Cells in Patients with Solid Tumors
  6. Altmetric Badge
    Chapter 5 Flow Cytometric Methods for Circulating Tumor Cell Isolation and Molecular Analysis
  7. Altmetric Badge
    Chapter 6 Enrichment and Detection of Circulating Tumor Cells and Other Rare Cell Populations by Microfluidic Filtration
  8. Altmetric Badge
    Chapter 7 Detection and Enumeration of Circulating Tumor Cells with Invasive Phenotype
  9. Altmetric Badge
    Chapter 8 Molecular Profiling and Significance of Circulating Tumor Cell Based Genetic Signatures
  10. Altmetric Badge
    Chapter 9 Detection of Gene Rearrangements in Circulating Tumor Cells: Examples of ALK-, ROS1-, RET-Rearrangements in Non-Small-Cell Lung Cancer and ERG-Rearrangements in Prostate Cancer
  11. Altmetric Badge
    Chapter 10 Enrichment, Isolation and Molecular Characterization of EpCAM-Negative Circulating Tumor Cells
  12. Altmetric Badge
    Chapter 11 Expression of Epithelial Mesenchymal Transition and Cancer Stem Cell Markers in Circulating Tumor Cells
  13. Altmetric Badge
    Chapter 12 Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer
  14. Altmetric Badge
    Chapter 13 Clinical Relevance of a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR) Expression in Circulating Tumor Cells
  15. Altmetric Badge
    Chapter 14 Personalized Treatment Through Detection and Monitoring of Genetic Aberrations in Single Circulating Tumor Cells
  16. Altmetric Badge
    Chapter 15 Glycan Markers as Potential Immunological Targets in Circulating Tumor Cells
  17. Altmetric Badge
    Chapter 16 Significance of EGFR Expression in Circulating Tumor Cells
Attention for Chapter 15: Glycan Markers as Potential Immunological Targets in Circulating Tumor Cells
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
1 news outlet
twitter
7 X users
patent
1 patent

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Glycan Markers as Potential Immunological Targets in Circulating Tumor Cells
Chapter number 15
Book title
Isolation and Molecular Characterization of Circulating Tumor Cells
Published in
Advances in experimental medicine and biology, May 2017
DOI 10.1007/978-3-319-55947-6_15
Pubmed ID
Book ISBNs
978-3-31-955946-9, 978-3-31-955947-6
Authors

Wang, Denong, Wu, Lisa, Liu, Xiaohe, Denong Wang, Lisa Wu, Xiaohe Liu

Abstract

We present here an experimental approach for exploring a new class of tumor biomarkers that are overexpressed by circulating tumor cells (CTCs) and are likely targetable in immunotherapy against tumor metastasis. Using carbohydrate microarrays, anti-tumor monoclonal antibodies (mAbs) were scanned against a large panel of carbohydrate antigens to identify potential tumor glycan markers. Subsequently, flow cytometry and fiber-optic array scanning technology (FAST) were applied to determine whether the identified targets are tumor-specific cell-surface markers and are, therefore, likely suitable for targeted immunotherapy. Finally, the tumor glycan-specific antibodies identified were validated using cancer patients' blood samples for their performance in CTC-detection and immunotyping analysis. In this article, identifying breast CTC-specific glycan markers and targeting mAbs serve as examples to illustrate this tumor biomarker discovery strategy.

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 24%
Student > Bachelor 3 18%
Researcher 2 12%
Student > Ph. D. Student 1 6%
Other 1 6%
Other 1 6%
Unknown 5 29%
Readers by discipline Count As %
Agricultural and Biological Sciences 4 24%
Biochemistry, Genetics and Molecular Biology 3 18%
Medicine and Dentistry 2 12%
Neuroscience 1 6%
Chemistry 1 6%
Other 1 6%
Unknown 5 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 June 2023.
All research outputs
#1,980,029
of 24,462,749 outputs
Outputs from Advances in experimental medicine and biology
#284
of 5,202 outputs
Outputs of similar age
#37,987
of 320,559 outputs
Outputs of similar age from Advances in experimental medicine and biology
#12
of 123 outputs
Altmetric has tracked 24,462,749 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,202 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 320,559 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 123 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.